Consistent with these findings, our immunohistochemical and Western blot analyses revealed a recovery of CB1R protein level in the hippocampus of two different HD mouse models (R6/1 and Hdh Q7/Q111 mice) following sub-chronic WIN treatment. This evidence concerns the gene CNR1 and Huntington disease.